Effect of a Humanoid Robot With Virtual Reality Games to Train Arm Function in Children With Cerebral Palsy - THRIVE Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-21
SponsorGeorgia State University

About this trial

About 60% of children with cerebral palsy (CP) have impaired arm function. Improving arm function requires hundreds of repetitions per day, which is impossible in a single clinical visit. Thus, therapeutic exercises should be sustained in the home environment; however, the compliance in performing home exercise is low due to poor motivation, boredom, and forgetfulness. A better home program is needed. The objective of this project is to examine the effect of our developed "THRIVE" system (Therapeutic Humanoid Robot In Virtual Environment: the combination of robot with virtual reality games), which can provide a motivating and tailored upper-extremity intervention program with instant feedback, to improve arm function in children with CP at their home. The investigators believe the newly developed "THRIVE" system can increase children's engagement and motivation in home exercises as the robot is their playmate to demonstrate and correct their movements. The investigators will also interview parents and children with CP to understand their impression of using technology at home to shape the intervention. The expected outcome is that children with CP receiving "THRIVE" will improve their arm function more and have better engagement than those who receive VR alone immediately after intervention and at follow-up. The long-term goal is to have the "THRIVE" system be the optimal home exercise platform as it can provide challenging but motivating exercises to improve children's arm function while assisting parents in supervising their children with CP to complete home exercises.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Participants are between the ages of 5 and 21 years;

diagnosed with spastic CP;

have a manual ability classification system (MACs) level I-III;

able to sit with trunk supported;

Disqualifiers

they have received surgery or botulinum toxin type A injection in the training arm within the preceding 4 months or are scheduled to receive it during the planned intervention period, or

if they have a severe attention deficit or uncontrolled epilepsy, which may possibly be triggered by the light or sound of the video games.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Robot

    Device

    This robot will serve as a cheerleader and coach to provide encouragement and feedback.

  • Virtual Reality

    Device

    Our developed Super Pop VR system will be used to provide virtual reality intervention.

Treatment groups

42 Participants
are divided into 2 treatment groups
Group A: THRIVE (Combination of Virtual Reality and Humanoid Robot)Experimental treatment 2 interventions
Group B: Virtual Reality AloneActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Reaching kinematics

Reaching kinematics will be assessed while the child is interacting with Super Pop VR, wherein virtual bubbles are projected onto the standard projecting screen in randomly dispersed locations using the Kinect system. Three testing bubbles will be situated in the location where children need to reach about arm length overhead at 180°, 135°, and 90° of shoulder abduction, with instructions for children to reach in two conditions: (1) as fast as possible and (2) as accurate as possible. Children's reaching kinematics will also be assessed while playing the real-life functional activity using the Kinect camera. All children will be seated in an adjustable chair with a testing table in front of them at waist height with trunk support. Data will be collected for a minimum of six reaches for each direction of virtual and real-life tasks.

Time frame
Baseline, at 9th week, and at 13th week.
2

Standardized fine motor assessment score

The fine motor domain of the Peabody Developmental Motor Scales, 2nd edition (PDMS-2), including grasping and visual-motor integration will be used. The higher score the better.

Time frame
Baseline, at 9th week, and at 13th week.
3

Daily use of affected hand

Daily use of affected hand will be evaluated using the Revised Pediatric Motor Activity Log (R-PMAL), which is filled out by primary caregivers about how often and how well their child uses the affected arm in daily activities.

Time frame
Baseline, at 9th week, and at 13th week.

Secondary outcomes

1

Muscle strength

Muscle strength of shoulder flexion, extension, abductor, adduction, external rotation, internal rotation, elbow flexion and extension, and wrist flexion and extension will be measured using a hand-held dynamometer prior to and after intervention as well as at follow-up.

Time frame
Baseline, at 9th week, and at 13th week.
2

Range of Motion (ROM)

ROM of shoulder flexion, extension, abduction, adduction, external rotation, internal rotation, elbow flexion and extension, and wrist flexion and extension will be measured using a standardized goniometer.

Time frame
Baseline, at 9th week, and at 13th week.
3

Spasticity

Spasticity of shoulder flexion, extension, abduction, adduction, external rotation, internal rotation, elbow flexion and extension, and wrist flexion and extension will also be measured using the Modified Ashworth Scale. It contains a scale of 0 to 4 with 0 as no spasticity to 4 as rigid in flexion or extension.

Time frame
Baseline, at 9th week, and at 13th week.

Other outcomes

1

Qualitative outcome

Researcher will conduct semi-structured interview to explore the parents' and children's expectations (pre-intervention) and perceptions (post-intervention and follow-up) as well as knowledge (all 3 timepoints) about the technology we used to conduct the intervention and about the barriers and facilitators to have parents implement the technology.

Time frame
Baseline, at 9th week, and at 13th week.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Georgia State University

Lead sponsor

Ohio State University

Collaborator